论文信息 - 1076O Adjuvant nivolumab (NIVO) vs ipilimumab (IPI) in resected stage III/IV melanoma: 4-y recurrence-free and overall survival (OS) results from CheckMate 238 - 字舞流文

1076O Adjuvant nivolumab (NIVO) vs ipilimumab (IPI) in resected stage III/IV melanoma: 4-y recurrence-free and overall survival (OS) results from CheckMate 238

P. Ascierto | J. Larkin | M. Mandalà | H. Gogas | J. Grob | M. Maio | S. Dalle | J. Weber | M. Butler | M. Middleton | M. Schenker | I. Márquez-Rodas | C. L. Cowey | M. Vecchio | A. Fernandez | M. Lobo | V. D. Pril | L. Merino | V. C. Sileni